| Hao Li; Helge Eduard RASK-ANDERSEN; Dan JIang; Gerard Mary O’DONOGHUE; Douglas Edward Hugh HARTLEY et al. (2024). Method for the treatment of an auditory disease or condition. Patent Number: US20240074967A1. |
BMIT-ID |
Patent |
Health |
| Haotian WANG; Jung Yoon KIM; Peng ZHU (2023). Electrochemical carbon dioxide capture and recovery in a solid electrolyte reactor system. Patent Number: WO2023201039A1. |
SXRMB |
Patent |
Materials |
| Hedda WARDEMANN; Rajagopal Murugan; Tizian Decker; Eiena Levashina; Giulia COSTA et al. (2022). Plasmodium antibodies. Patent Number: US20220396614A1. |
CMCF-ID |
Patent |
Health |
| Jafar SOLTAN; Nazanin Charchi AGHDAM (2023). Method for the preparation of alkene oxides using ozone at room temperature. Patent Number: WO2023159315A1. |
HXMA |
Patent |
Materials |
| Jason Chin; Nicolas HUGUENIN-DEZOT; Mohan MAHESH; Shan Tang; Duy P. Nguyen et al. (2022). Methods and compositions. Patent Number: US20220010296A1. |
CMCF-ID |
Patent |
Health |
| Jason Rolfe; Mehran Khodabandeh; Zaccary ALPERSTEIN; Seyed Ali Saberali; Hazem MSLATI et al. (2024). Protease inhibitors and methods of using same. Patent Number: WO2024130411A1. |
CMCF-BM |
Patent |
Health |
| Jean-Philippe Julien; Taylor Sicard; Anthony Semesi; Bebhinn Treanor; Tiantian Zhao et al. (2025). Nanoparticle platform for antibody and vaccine delivery. Patent Number: US20250114475A1. |
CMCF-ID |
Patent |
Health |
| Jehad ABED; Steven Thorpe; Edward Sargent (2025). Electrocatalysts comprising transition metals and chalcogen for oxygen evolution reactions (OER) and manufacturing thereof. Patent Number: US12234157B2. |
CLS-APS, SGM |
Patent |
Materials |
| Jehad ABED; Steven Thorpe; Edward Sargent (2025). Electrocatalysts comprising transition metals and chalcogen for oxygen evolution reactions (OER) and manufacturing thereof. Patent Number: US12234157B2. |
CLS-APS, SGM |
Patent |
Materials |
| Joan Seoane Suarez; Judit ANIDO FOLGUEIRA; Robin Matthew Hallett; Patricia Anne GIBLIN; Jeanne MAGRAM et al. (2021). Combination of lif inhibitors and platinum-based antineoplastic agents for use in treating cancer. Patent Number: US20210187106A1. |
CMCF-ID |
Patent |
Health |
| Joan Seoane Suarez; Judit ANIDO FOLGUEIRA; Robin Matthew Hallett; Peter Edward BAYLISS; Ajitha JEGANATHAN et al. (2021). Methods for improving response to anti-lif antibody treatment in individuals with cancer. Patent Number: US20210253691A1. |
CMCF-ID |
Patent |
Health |
| Jorg Stetefeld (2020). Netrin- 1 and dependence receptor proteins and method of use. Patent Number: US20200165308A1. |
CMCF-BM |
Patent |
Health |
| Juan P. Ianowski; Julian S. Tam; Xiaojie Luan; Veronica A. Campanucci (2021). Neuronal agonists and isotonic or hypertonic saline for treating respiratory diseases. Patent Number: US20210228511A1. |
BMIT-BM |
Patent |
Health |
| Judit Anido Folgueira; Patricia Anne Giblin; Robin Matthew Hallett; Jeanne Magram; Naimish PANDYA et al. (2024). Combination of lif inhibitors and platinum-based antineoplastic agents for use in treating cancer. Patent Number: AU2024204564A1. |
CMCF-ID |
Patent |
Health |
| Kelsey Sivick GAUTHIER; Nigel Pelham Clinton Walker; Xiaoning ZHAO; John Lippincott (2024). Antibodies to tigit. Patent Number: US20240182570A1. |
CMCF-ID |
Patent |
Health |